Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)

National Institutes of Health

Federal funding opportunity PAR-25-069 published by National Institutes of Health. Review the official synopsis for eligibility, award terms, and application requirements.